Travis Nemkov
Concepts (631)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Erythrocytes | 56 | 2026 | 749 | 8.090 |
Why?
| | Blood Preservation | 31 | 2026 | 346 | 4.530 |
Why?
| | Metabolomics | 35 | 2026 | 733 | 4.000 |
Why?
| | Metabolome | 25 | 2026 | 391 | 2.820 |
Why?
| | Hemolysis | 13 | 2025 | 242 | 2.620 |
Why?
| | Glycolysis | 23 | 2025 | 340 | 2.280 |
Why?
| | Blood Donors | 11 | 2025 | 144 | 2.250 |
Why?
| | High-Throughput Screening Assays | 5 | 2026 | 177 | 1.980 |
Why?
| | Erythrocyte Transfusion | 14 | 2026 | 225 | 1.550 |
Why?
| | Drosophila melanogaster | 11 | 2025 | 239 | 1.490 |
Why?
| | Mass Spectrometry | 12 | 2026 | 732 | 1.450 |
Why?
| | Transfusion Medicine | 2 | 2026 | 19 | 1.370 |
Why?
| | Drosophila Proteins | 10 | 2025 | 214 | 1.350 |
Why?
| | Carnitine | 4 | 2024 | 91 | 1.030 |
Why?
| | Hypoxia | 11 | 2024 | 1199 | 0.980 |
Why?
| | Energy Metabolism | 11 | 2024 | 935 | 0.930 |
Why?
| | Oxidative Stress | 15 | 2025 | 1360 | 0.920 |
Why?
| | Amino Acids | 10 | 2023 | 519 | 0.900 |
Why?
| | Animals | 78 | 2026 | 38102 | 0.860 |
Why?
| | Membrane Lipids | 2 | 2021 | 82 | 0.790 |
Why?
| | Mice | 45 | 2026 | 18356 | 0.790 |
Why?
| | Hematopoietic Stem Cells | 5 | 2026 | 435 | 0.790 |
Why?
| | Hemoglobins | 6 | 2025 | 386 | 0.780 |
Why?
| | Proteomics | 8 | 2025 | 1188 | 0.750 |
Why?
| | Shock, Hemorrhagic | 7 | 2020 | 199 | 0.740 |
Why?
| | Erythroblasts | 1 | 2022 | 18 | 0.720 |
Why?
| | Blood Platelets | 5 | 2025 | 379 | 0.720 |
Why?
| | Athletic Performance | 1 | 2023 | 78 | 0.700 |
Why?
| | Glucosephosphate Dehydrogenase Deficiency | 4 | 2025 | 34 | 0.690 |
Why?
| | Purines | 4 | 2022 | 187 | 0.660 |
Why?
| | Lipid Metabolism | 6 | 2021 | 529 | 0.660 |
Why?
| | Nonprescription Drugs | 1 | 2021 | 69 | 0.630 |
Why?
| | Receptor, Adenosine A2B | 4 | 2025 | 65 | 0.620 |
Why?
| | Humans | 109 | 2026 | 145783 | 0.620 |
Why?
| | Physical Exertion | 1 | 2021 | 205 | 0.610 |
Why?
| | Leukemia | 2 | 2019 | 246 | 0.590 |
Why?
| | Glucosephosphate Dehydrogenase | 4 | 2025 | 70 | 0.590 |
Why?
| | Prescription Drugs | 1 | 2021 | 111 | 0.590 |
Why?
| | Carbon | 2 | 2017 | 176 | 0.570 |
Why?
| | Fatty Acids | 7 | 2024 | 457 | 0.570 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2025 | 298 | 0.560 |
Why?
| | Lymph | 2 | 2016 | 31 | 0.560 |
Why?
| | Iron | 3 | 2025 | 359 | 0.550 |
Why?
| | Cell Death | 1 | 2020 | 382 | 0.540 |
Why?
| | Hypoxanthine | 1 | 2017 | 11 | 0.530 |
Why?
| | Leukemia, Myeloid, Acute | 7 | 2020 | 688 | 0.530 |
Why?
| | Muscle, Skeletal | 9 | 2025 | 1791 | 0.510 |
Why?
| | Anemia | 3 | 2024 | 191 | 0.500 |
Why?
| | Bone Marrow | 1 | 2018 | 307 | 0.500 |
Why?
| | Oxidation-Reduction | 11 | 2025 | 1069 | 0.490 |
Why?
| | Myelodysplastic Syndromes | 3 | 2026 | 165 | 0.490 |
Why?
| | Nitrogen | 1 | 2017 | 125 | 0.480 |
Why?
| | Aging | 8 | 2024 | 1973 | 0.480 |
Why?
| | Altitude Sickness | 5 | 2018 | 141 | 0.480 |
Why?
| | Exercise Tolerance | 3 | 2025 | 283 | 0.460 |
Why?
| | Biomarkers | 10 | 2024 | 4302 | 0.440 |
Why?
| | Kynurenine | 5 | 2024 | 114 | 0.440 |
Why?
| | Mice, Inbred C57BL | 18 | 2026 | 5993 | 0.430 |
Why?
| | Inflammation | 7 | 2024 | 2884 | 0.420 |
Why?
| | Male | 54 | 2025 | 73011 | 0.420 |
Why?
| | Exercise | 3 | 2023 | 2205 | 0.410 |
Why?
| | Proteome | 5 | 2025 | 513 | 0.400 |
Why?
| | Lipids | 1 | 2019 | 707 | 0.400 |
Why?
| | Mitochondria | 8 | 2025 | 993 | 0.400 |
Why?
| | Adenosine Triphosphate | 3 | 2025 | 500 | 0.390 |
Why?
| | Taste Buds | 1 | 2015 | 214 | 0.370 |
Why?
| | Female | 52 | 2026 | 79045 | 0.350 |
Why?
| | Neoplastic Stem Cells | 4 | 2021 | 409 | 0.350 |
Why?
| | Healthy Volunteers | 7 | 2021 | 219 | 0.350 |
Why?
| | Extracellular Vesicles | 2 | 2025 | 171 | 0.340 |
Why?
| | Chromatography, High Pressure Liquid | 7 | 2019 | 592 | 0.340 |
Why?
| | Hemorrhage | 2 | 2022 | 822 | 0.330 |
Why?
| | Oxygen | 5 | 2020 | 981 | 0.330 |
Why?
| | Adaptation, Physiological | 4 | 2018 | 560 | 0.310 |
Why?
| | Flavones | 2 | 2019 | 11 | 0.300 |
Why?
| | Adult | 29 | 2025 | 40881 | 0.300 |
Why?
| | Glutathione | 4 | 2025 | 370 | 0.300 |
Why?
| | Drug Resistance, Neoplasm | 3 | 2021 | 883 | 0.300 |
Why?
| | Bridged Bicyclo Compounds, Heterocyclic | 3 | 2020 | 280 | 0.290 |
Why?
| | Sphingosine | 3 | 2023 | 47 | 0.290 |
Why?
| | Altitude | 4 | 2023 | 463 | 0.290 |
Why?
| | Rats, Sprague-Dawley | 8 | 2020 | 2525 | 0.290 |
Why?
| | Blood Banks | 3 | 2019 | 50 | 0.290 |
Why?
| | Lysophospholipids | 3 | 2023 | 80 | 0.290 |
Why?
| | Adenine | 2 | 2025 | 339 | 0.270 |
Why?
| | Neoplasm Proteins | 2 | 2025 | 442 | 0.270 |
Why?
| | Alcohol Oxidoreductases | 2 | 2025 | 61 | 0.270 |
Why?
| | Polyamines | 3 | 2024 | 42 | 0.270 |
Why?
| | Niacinamide | 2 | 2026 | 104 | 0.260 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2025 | 1217 | 0.260 |
Why?
| | Acclimatization | 3 | 2018 | 170 | 0.260 |
Why?
| | Cold Temperature | 3 | 2025 | 206 | 0.250 |
Why?
| | Blood Transfusion | 4 | 2024 | 409 | 0.250 |
Why?
| | RNA-Binding Proteins | 3 | 2023 | 447 | 0.250 |
Why?
| | Thrombosis | 2 | 2022 | 400 | 0.250 |
Why?
| | Arginine | 3 | 2024 | 264 | 0.250 |
Why?
| | fms-Like Tyrosine Kinase 3 | 2 | 2017 | 51 | 0.250 |
Why?
| | Hematopoiesis | 2 | 2018 | 193 | 0.250 |
Why?
| | Larva | 6 | 2025 | 240 | 0.250 |
Why?
| | Mammals | 3 | 2023 | 286 | 0.240 |
Why?
| | Erythrocyte Aging | 2 | 2024 | 12 | 0.240 |
Why?
| | Sciuridae | 2 | 2019 | 152 | 0.240 |
Why?
| | Gene Expression Regulation, Leukemic | 2 | 2016 | 56 | 0.240 |
Why?
| | Plasma | 3 | 2017 | 223 | 0.240 |
Why?
| | Oxygen Consumption | 4 | 2024 | 719 | 0.240 |
Why?
| | Chemokine CXCL13 | 1 | 2026 | 15 | 0.240 |
Why?
| | Cell Line, Tumor | 11 | 2026 | 3551 | 0.240 |
Why?
| | Signal Transduction | 9 | 2025 | 5224 | 0.240 |
Why?
| | Cysteine | 2 | 2025 | 211 | 0.230 |
Why?
| | Isotope Labeling | 2 | 2017 | 82 | 0.230 |
Why?
| | Focal Adhesion Kinase 1 | 1 | 2026 | 32 | 0.230 |
Why?
| | Tryptophan | 4 | 2021 | 182 | 0.230 |
Why?
| | Wolbachia | 1 | 2025 | 3 | 0.230 |
Why?
| | Amino Acids, Branched-Chain | 1 | 2026 | 39 | 0.230 |
Why?
| | Anti-Inflammatory Agents | 2 | 2021 | 478 | 0.230 |
Why?
| | Mice, Knockout | 6 | 2025 | 3130 | 0.230 |
Why?
| | Macrophages, Peritoneal | 1 | 2026 | 89 | 0.230 |
Why?
| | Insulin Resistance | 3 | 2021 | 1244 | 0.230 |
Why?
| | Maternal Nutritional Physiological Phenomena | 2 | 2018 | 178 | 0.230 |
Why?
| | Collagen | 2 | 2020 | 457 | 0.230 |
Why?
| | Drosophila | 2 | 2024 | 166 | 0.230 |
Why?
| | Erythropoiesis | 2 | 2023 | 57 | 0.230 |
Why?
| | Glycerolphosphate Dehydrogenase | 1 | 2025 | 5 | 0.230 |
Why?
| | Qa-SNARE Proteins | 1 | 2025 | 18 | 0.230 |
Why?
| | Rats | 7 | 2021 | 5585 | 0.220 |
Why?
| | Wounds and Injuries | 3 | 2020 | 962 | 0.220 |
Why?
| | Pneumonia, Viral | 2 | 2020 | 391 | 0.220 |
Why?
| | Interleukin-1 | 2 | 2021 | 961 | 0.220 |
Why?
| | Coronavirus Infections | 2 | 2020 | 384 | 0.220 |
Why?
| | L-Lactate Dehydrogenase | 1 | 2025 | 112 | 0.220 |
Why?
| | Polymorphism, Genetic | 2 | 2025 | 615 | 0.220 |
Why?
| | Caffeine | 1 | 2025 | 74 | 0.220 |
Why?
| | Pentose Phosphate Pathway | 4 | 2018 | 55 | 0.220 |
Why?
| | Symbiosis | 1 | 2025 | 72 | 0.220 |
Why?
| | Primaquine | 1 | 2024 | 7 | 0.210 |
Why?
| | GTP Phosphohydrolases | 1 | 2025 | 93 | 0.210 |
Why?
| | Homeodomain Proteins | 2 | 2020 | 523 | 0.210 |
Why?
| | Phosphofructokinases | 1 | 2024 | 7 | 0.210 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2026 | 143 | 0.210 |
Why?
| | Solute Carrier Family 22 Member 5 | 1 | 2024 | 7 | 0.210 |
Why?
| | Hexokinase | 1 | 2024 | 18 | 0.210 |
Why?
| | Rejuvenation | 1 | 2024 | 18 | 0.210 |
Why?
| | Physical Conditioning, Animal | 2 | 2025 | 242 | 0.210 |
Why?
| | Stress, Physiological | 2 | 2025 | 443 | 0.210 |
Why?
| | Triple Negative Breast Neoplasms | 2 | 2018 | 218 | 0.200 |
Why?
| | Cardiorespiratory Fitness | 1 | 2024 | 74 | 0.200 |
Why?
| | Large Neutral Amino Acid-Transporter 1 | 1 | 2024 | 17 | 0.200 |
Why?
| | Mitochondria, Muscle | 3 | 2021 | 120 | 0.200 |
Why?
| | In Vitro Techniques | 3 | 2021 | 1049 | 0.200 |
Why?
| | Blood Group Antigens | 1 | 2023 | 15 | 0.200 |
Why?
| | Rh-Hr Blood-Group System | 1 | 2023 | 15 | 0.200 |
Why?
| | DNA, Mitochondrial | 1 | 2025 | 211 | 0.200 |
Why?
| | Pyruvate Kinase | 1 | 2023 | 29 | 0.200 |
Why?
| | Erythrocyte Deformability | 2 | 2021 | 23 | 0.200 |
Why?
| | Uric Acid | 1 | 2025 | 167 | 0.200 |
Why?
| | Chromatography, Liquid | 3 | 2025 | 450 | 0.200 |
Why?
| | Emtricitabine | 1 | 2025 | 210 | 0.200 |
Why?
| | Epithelial-Mesenchymal Transition | 3 | 2021 | 220 | 0.200 |
Why?
| | Glutamine | 3 | 2019 | 109 | 0.200 |
Why?
| | Isoenzymes | 1 | 2024 | 295 | 0.200 |
Why?
| | Middle Aged | 15 | 2025 | 36309 | 0.200 |
Why?
| | Phosphotransferases (Alcohol Group Acceptor) | 2 | 2021 | 49 | 0.200 |
Why?
| | Satellite Cells, Skeletal Muscle | 1 | 2023 | 35 | 0.190 |
Why?
| | Succinates | 1 | 2023 | 25 | 0.190 |
Why?
| | Cerebral Hemorrhage | 1 | 2024 | 125 | 0.190 |
Why?
| | Lactates | 1 | 2023 | 82 | 0.190 |
Why?
| | Oxidative Phosphorylation | 3 | 2018 | 209 | 0.190 |
Why?
| | Furin | 1 | 2022 | 12 | 0.190 |
Why?
| | Tenofovir | 1 | 2025 | 301 | 0.190 |
Why?
| | Pluripotent Stem Cells | 1 | 2023 | 81 | 0.190 |
Why?
| | Gonadotropin-Releasing Hormone | 1 | 2024 | 217 | 0.190 |
Why?
| | Down-Regulation | 1 | 2025 | 618 | 0.190 |
Why?
| | 2,3-Diphosphoglycerate | 5 | 2023 | 32 | 0.190 |
Why?
| | Mitochondrial Proteins | 1 | 2025 | 263 | 0.190 |
Why?
| | Streptococcus pneumoniae | 1 | 2025 | 186 | 0.190 |
Why?
| | Autophagy | 1 | 2025 | 291 | 0.190 |
Why?
| | Protein Processing, Post-Translational | 3 | 2025 | 473 | 0.190 |
Why?
| | Equidae | 1 | 2022 | 7 | 0.180 |
Why?
| | src-Family Kinases | 1 | 2023 | 92 | 0.180 |
Why?
| | Histiocytosis | 1 | 2022 | 9 | 0.180 |
Why?
| | Alleles | 1 | 2025 | 896 | 0.180 |
Why?
| | Obesity | 5 | 2021 | 3118 | 0.180 |
Why?
| | Bicycling | 1 | 2023 | 117 | 0.180 |
Why?
| | AMP-Activated Protein Kinases | 3 | 2022 | 192 | 0.180 |
Why?
| | Glucose | 3 | 2017 | 1049 | 0.180 |
Why?
| | Peptide Hydrolases | 1 | 2022 | 105 | 0.180 |
Why?
| | Liver | 3 | 2019 | 1899 | 0.180 |
Why?
| | Erdheim-Chester Disease | 1 | 2021 | 4 | 0.180 |
Why?
| | Neutrophils | 2 | 2025 | 1127 | 0.170 |
Why?
| | Sulfonamides | 3 | 2020 | 583 | 0.170 |
Why?
| | Embryo, Mammalian | 1 | 2022 | 234 | 0.170 |
Why?
| | Cholesterol | 2 | 2022 | 408 | 0.170 |
Why?
| | Asparagine | 2 | 2018 | 35 | 0.170 |
Why?
| | Ranitidine | 1 | 2021 | 14 | 0.170 |
Why?
| | Sphingolipids | 2 | 2021 | 83 | 0.170 |
Why?
| | Erythrocyte Count | 1 | 2021 | 21 | 0.170 |
Why?
| | Lactic Acid | 5 | 2024 | 295 | 0.170 |
Why?
| | Auditory Pathways | 1 | 2021 | 53 | 0.170 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 2 | 2019 | 192 | 0.170 |
Why?
| | Protein Domains | 1 | 2022 | 311 | 0.170 |
Why?
| | Metabolic Networks and Pathways | 2 | 2019 | 175 | 0.170 |
Why?
| | Transgender Persons | 1 | 2024 | 210 | 0.170 |
Why?
| | Stearoyl-CoA Desaturase | 1 | 2021 | 66 | 0.160 |
Why?
| | Fatty Acid Desaturases | 1 | 2021 | 31 | 0.160 |
Why?
| | Metformin | 1 | 2024 | 329 | 0.160 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 1 | 2022 | 254 | 0.160 |
Why?
| | Syndecan-1 | 1 | 2020 | 43 | 0.160 |
Why?
| | Virulence Factors | 1 | 2022 | 175 | 0.160 |
Why?
| | Resistance Training | 1 | 2023 | 186 | 0.160 |
Why?
| | Benzothiazoles | 2 | 2017 | 39 | 0.160 |
Why?
| | Testosterone | 1 | 2024 | 416 | 0.160 |
Why?
| | Genome-Wide Association Study | 2 | 2024 | 1430 | 0.160 |
Why?
| | Cell Plasticity | 1 | 2021 | 37 | 0.160 |
Why?
| | Cellular Reprogramming | 2 | 2021 | 98 | 0.160 |
Why?
| | Cellular Microenvironment | 1 | 2021 | 94 | 0.160 |
Why?
| | Stromal Cells | 1 | 2020 | 121 | 0.160 |
Why?
| | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2021 | 128 | 0.160 |
Why?
| | Aged | 8 | 2024 | 26217 | 0.160 |
Why?
| | Small Molecule Libraries | 1 | 2021 | 111 | 0.160 |
Why?
| | Tandem Mass Spectrometry | 3 | 2025 | 572 | 0.150 |
Why?
| | Osmotic Pressure | 1 | 2020 | 41 | 0.150 |
Why?
| | Macrophage Activation | 1 | 2021 | 181 | 0.150 |
Why?
| | Phosphatidylserines | 1 | 2020 | 62 | 0.150 |
Why?
| | TCF Transcription Factors | 1 | 2019 | 19 | 0.150 |
Why?
| | Cannabinoids | 1 | 2022 | 184 | 0.150 |
Why?
| | Taurine | 1 | 2020 | 41 | 0.150 |
Why?
| | Cannabidiol | 1 | 2022 | 142 | 0.150 |
Why?
| | Phenylurea Compounds | 2 | 2017 | 119 | 0.150 |
Why?
| | Topoisomerase II Inhibitors | 1 | 2019 | 24 | 0.150 |
Why?
| | Macrophages | 4 | 2022 | 1507 | 0.150 |
Why?
| | Time Factors | 10 | 2024 | 7134 | 0.150 |
Why?
| | Ovarian Neoplasms | 1 | 2026 | 596 | 0.150 |
Why?
| | Transcription Factors | 2 | 2025 | 1736 | 0.150 |
Why?
| | Proto-Oncogene Proteins B-raf | 1 | 2021 | 224 | 0.150 |
Why?
| | Parabiosis | 1 | 2019 | 11 | 0.150 |
Why?
| | STAT3 Transcription Factor | 1 | 2021 | 206 | 0.150 |
Why?
| | Hibernation | 2 | 2019 | 82 | 0.150 |
Why?
| | Shock | 1 | 2020 | 110 | 0.150 |
Why?
| | Tryptophan Oxygenase | 2 | 2018 | 33 | 0.150 |
Why?
| | Hydrogen Peroxide | 1 | 2021 | 335 | 0.150 |
Why?
| | Torpor | 1 | 2019 | 19 | 0.140 |
Why?
| | Cell Proliferation | 6 | 2026 | 2514 | 0.140 |
Why?
| | Circadian Clocks | 1 | 2019 | 59 | 0.140 |
Why?
| | Thyroid Neoplasms | 1 | 2023 | 370 | 0.140 |
Why?
| | Quantitative Trait Loci | 3 | 2025 | 381 | 0.140 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2025 | 923 | 0.140 |
Why?
| | Cigarette Smoking | 1 | 2020 | 102 | 0.140 |
Why?
| | Homeostasis | 2 | 2022 | 644 | 0.140 |
Why?
| | Hydrogen-Ion Concentration | 3 | 2024 | 532 | 0.140 |
Why?
| | Gene-Environment Interaction | 1 | 2020 | 180 | 0.140 |
Why?
| | Aspartic Acid | 1 | 2018 | 88 | 0.140 |
Why?
| | Blood Specimen Collection | 1 | 2018 | 37 | 0.140 |
Why?
| | Machine Learning | 2 | 2021 | 587 | 0.140 |
Why?
| | Anemia, Sickle Cell | 2 | 2024 | 318 | 0.140 |
Why?
| | Adenosine | 2 | 2017 | 255 | 0.140 |
Why?
| | Hypertension, Pulmonary | 2 | 2021 | 1957 | 0.140 |
Why?
| | Arousal | 1 | 2019 | 157 | 0.140 |
Why?
| | Renal Insufficiency | 1 | 2020 | 172 | 0.140 |
Why?
| | Bile Acids and Salts | 1 | 2019 | 163 | 0.140 |
Why?
| | Stem Cell Niche | 1 | 2018 | 57 | 0.140 |
Why?
| | Deamination | 1 | 2017 | 6 | 0.130 |
Why?
| | Proteostasis | 1 | 2018 | 27 | 0.130 |
Why?
| | Erythrocytes, Abnormal | 1 | 2017 | 14 | 0.130 |
Why?
| | Hemoglobin A | 1 | 2017 | 21 | 0.130 |
Why?
| | Macrophages, Alveolar | 1 | 2021 | 373 | 0.130 |
Why?
| | Vascular Diseases | 1 | 2020 | 252 | 0.130 |
Why?
| | Hemoglobin, Sickle | 1 | 2017 | 20 | 0.130 |
Why?
| | Transcriptome | 2 | 2021 | 1042 | 0.130 |
Why?
| | Benzeneacetamides | 1 | 2017 | 8 | 0.130 |
Why?
| | Diglycerides | 1 | 2018 | 61 | 0.130 |
Why?
| | Glutaminase | 1 | 2017 | 11 | 0.130 |
Why?
| | Cryopreservation | 1 | 2018 | 113 | 0.130 |
Why?
| | Disease Models, Animal | 7 | 2025 | 4568 | 0.130 |
Why?
| | Thiadiazoles | 1 | 2017 | 25 | 0.130 |
Why?
| | Calcium | 2 | 2022 | 1191 | 0.130 |
Why?
| | Nicotine | 1 | 2020 | 331 | 0.130 |
Why?
| | Anti-HIV Agents | 1 | 2025 | 912 | 0.130 |
Why?
| | Folic Acid Deficiency | 1 | 2017 | 49 | 0.130 |
Why?
| | Immune System | 1 | 2018 | 180 | 0.130 |
Why?
| | Equilibrative Nucleoside Transporter 1 | 1 | 2017 | 19 | 0.130 |
Why?
| | Limit of Detection | 1 | 2017 | 92 | 0.130 |
Why?
| | Basigin | 1 | 2017 | 24 | 0.120 |
Why?
| | Resuscitation | 2 | 2018 | 312 | 0.120 |
Why?
| | Tumor Microenvironment | 2 | 2018 | 735 | 0.120 |
Why?
| | Body Fluids | 1 | 2017 | 71 | 0.120 |
Why?
| | Mutation | 6 | 2025 | 4090 | 0.120 |
Why?
| | Citric Acid | 1 | 2016 | 33 | 0.120 |
Why?
| | Glyceraldehyde 3-Phosphate Dehydrogenase (NADP+) | 1 | 2016 | 7 | 0.120 |
Why?
| | Nitriles | 1 | 2018 | 211 | 0.120 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2024 | 2181 | 0.120 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2018 | 166 | 0.120 |
Why?
| | Ataxia Telangiectasia Mutated Proteins | 1 | 2016 | 69 | 0.120 |
Why?
| | Bacteria | 1 | 2022 | 766 | 0.120 |
Why?
| | Inflammasomes | 1 | 2018 | 144 | 0.120 |
Why?
| | Saline Solution, Hypertonic | 1 | 2016 | 43 | 0.120 |
Why?
| | Young Adult | 8 | 2021 | 14254 | 0.120 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2018 | 337 | 0.120 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2016 | 106 | 0.120 |
Why?
| | Gene Expression Regulation, Developmental | 4 | 2025 | 910 | 0.120 |
Why?
| | Interleukin-6 | 1 | 2020 | 780 | 0.120 |
Why?
| | Folic Acid | 1 | 2017 | 198 | 0.120 |
Why?
| | Breast Neoplasms | 2 | 2020 | 2393 | 0.120 |
Why?
| | Models, Biological | 2 | 2021 | 1764 | 0.120 |
Why?
| | Diethylhexyl Phthalate | 1 | 2015 | 13 | 0.120 |
Why?
| | Phosphatidylethanolamines | 1 | 2016 | 77 | 0.120 |
Why?
| | Neoplasms | 2 | 2022 | 2913 | 0.120 |
Why?
| | Reperfusion Injury | 1 | 2018 | 292 | 0.120 |
Why?
| | Brain Death | 1 | 2016 | 60 | 0.110 |
Why?
| | Antioxidants | 1 | 2019 | 550 | 0.110 |
Why?
| | NF-E2-Related Factor 2 | 1 | 2016 | 101 | 0.110 |
Why?
| | Reactive Oxygen Species | 4 | 2022 | 611 | 0.110 |
Why?
| | Metabolic Flux Analysis | 1 | 2015 | 8 | 0.110 |
Why?
| | Membrane Transport Proteins | 1 | 2017 | 154 | 0.110 |
Why?
| | Biochemistry | 1 | 2015 | 36 | 0.110 |
Why?
| | Anoikis | 1 | 2015 | 31 | 0.110 |
Why?
| | Hydroxylysine | 1 | 2015 | 4 | 0.110 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2018 | 265 | 0.110 |
Why?
| | Acidosis | 1 | 2016 | 105 | 0.110 |
Why?
| | Phosphatidylcholines | 1 | 2016 | 131 | 0.110 |
Why?
| | Bronchoalveolar Lavage | 1 | 2015 | 89 | 0.110 |
Why?
| | Glutarates | 2 | 2025 | 11 | 0.110 |
Why?
| | Vasodilation | 1 | 2018 | 521 | 0.110 |
Why?
| | Receptors, Aryl Hydrocarbon | 1 | 2015 | 60 | 0.110 |
Why?
| | Cognitive Dysfunction | 1 | 2021 | 468 | 0.110 |
Why?
| | Fluid Therapy | 1 | 2016 | 155 | 0.110 |
Why?
| | Blood Volume | 1 | 2015 | 65 | 0.110 |
Why?
| | Pandemics | 2 | 2020 | 1711 | 0.110 |
Why?
| | Immunity, Innate | 1 | 2021 | 835 | 0.110 |
Why?
| | Citrates | 1 | 2014 | 41 | 0.110 |
Why?
| | Platelet Transfusion | 1 | 2015 | 77 | 0.110 |
Why?
| | Cytoskeletal Proteins | 1 | 2015 | 157 | 0.110 |
Why?
| | Brain Injuries, Traumatic | 1 | 2021 | 453 | 0.110 |
Why?
| | Cells, Cultured | 5 | 2021 | 4151 | 0.110 |
Why?
| | Mice, Transgenic | 4 | 2025 | 2191 | 0.110 |
Why?
| | Sulfur | 3 | 2022 | 60 | 0.110 |
Why?
| | Organ Preservation Solutions | 1 | 2014 | 46 | 0.110 |
Why?
| | Amyloid beta-Peptides | 1 | 2017 | 246 | 0.110 |
Why?
| | Extinction, Biological | 1 | 2015 | 33 | 0.110 |
Why?
| | Linear Models | 1 | 2017 | 849 | 0.110 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2021 | 668 | 0.110 |
Why?
| | Adipose Tissue | 2 | 2017 | 645 | 0.100 |
Why?
| | Reproducibility of Results | 2 | 2026 | 3418 | 0.100 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2017 | 638 | 0.100 |
Why?
| | Health Status | 1 | 2019 | 835 | 0.100 |
Why?
| | Sodium Chloride | 1 | 2014 | 138 | 0.100 |
Why?
| | Endothelium, Vascular | 1 | 2020 | 956 | 0.100 |
Why?
| | Phosphates | 1 | 2014 | 177 | 0.100 |
Why?
| | Methionine | 3 | 2020 | 161 | 0.100 |
Why?
| | Proteolysis | 3 | 2020 | 172 | 0.100 |
Why?
| | Heart Ventricles | 1 | 2018 | 756 | 0.100 |
Why?
| | Peptide Fragments | 1 | 2017 | 697 | 0.100 |
Why?
| | Fetal Development | 1 | 2016 | 298 | 0.100 |
Why?
| | Dietary Supplements | 1 | 2017 | 584 | 0.100 |
Why?
| | Glucose Tolerance Test | 3 | 2021 | 361 | 0.090 |
Why?
| | Antineoplastic Agents | 3 | 2019 | 2219 | 0.090 |
Why?
| | Diabetes Mellitus, Type 2 | 3 | 2023 | 2602 | 0.090 |
Why?
| | Muscles | 2 | 2023 | 330 | 0.090 |
Why?
| | Prognosis | 1 | 2021 | 4330 | 0.090 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2016 | 534 | 0.090 |
Why?
| | Nuclear Proteins | 1 | 2017 | 740 | 0.090 |
Why?
| | MicroRNAs | 1 | 2018 | 686 | 0.090 |
Why?
| | Diet | 1 | 2020 | 1278 | 0.090 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2018 | 655 | 0.090 |
Why?
| | Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating) | 2 | 2025 | 15 | 0.090 |
Why?
| | Nerve Tissue Proteins | 1 | 2015 | 592 | 0.090 |
Why?
| | Colorectal Neoplasms | 1 | 2019 | 868 | 0.080 |
Why?
| | Microbiota | 1 | 2018 | 730 | 0.080 |
Why?
| | Mice, Inbred NOD | 3 | 2017 | 616 | 0.080 |
Why?
| | Xenograft Model Antitumor Assays | 3 | 2019 | 936 | 0.080 |
Why?
| | Cytokines | 3 | 2026 | 2069 | 0.080 |
Why?
| | Liver Neoplasms | 1 | 2016 | 777 | 0.080 |
Why?
| | Epithelial Cells | 1 | 2016 | 1134 | 0.080 |
Why?
| | Cell Line | 3 | 2022 | 2823 | 0.080 |
Why?
| | Citric Acid Cycle | 2 | 2021 | 58 | 0.080 |
Why?
| | Protein Kinase Inhibitors | 3 | 2023 | 981 | 0.080 |
Why?
| | HIV Infections | 1 | 2025 | 3195 | 0.070 |
Why?
| | Bisphosphoglycerate Mutase | 2 | 2021 | 7 | 0.070 |
Why?
| | Insulin | 2 | 2021 | 2516 | 0.070 |
Why?
| | Cattle | 2 | 2022 | 946 | 0.070 |
Why?
| | Phenotype | 4 | 2020 | 3170 | 0.070 |
Why?
| | Glucose Clamp Technique | 2 | 2021 | 199 | 0.070 |
Why?
| | Phosphorylation | 3 | 2018 | 1708 | 0.070 |
Why?
| | Pancreatic Neoplasms | 1 | 2017 | 928 | 0.070 |
Why?
| | Fatty Acids, Nonesterified | 2 | 2020 | 154 | 0.070 |
Why?
| | Diet, High-Fat | 2 | 2019 | 266 | 0.070 |
Why?
| | Macaca | 2 | 2018 | 66 | 0.070 |
Why?
| | Adolescent | 3 | 2024 | 22577 | 0.060 |
Why?
| | Enzyme Activation | 2 | 2021 | 762 | 0.060 |
Why?
| | Betacoronavirus | 2 | 2020 | 289 | 0.060 |
Why?
| | Brain | 2 | 2021 | 2969 | 0.060 |
Why?
| | Microscopy, Electron, Scanning | 2 | 2018 | 196 | 0.060 |
Why?
| | Apoptosis | 3 | 2021 | 2444 | 0.060 |
Why?
| | Bacterial Proteins | 2 | 2025 | 968 | 0.060 |
Why?
| | Sex Characteristics | 2 | 2023 | 789 | 0.060 |
Why?
| | Nicotinamide Phosphoribosyltransferase | 1 | 2026 | 26 | 0.060 |
Why?
| | Gene Expression Regulation, Neoplastic | 3 | 2018 | 1450 | 0.060 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2016 | 1969 | 0.060 |
Why?
| | 5'-Nucleotidase | 2 | 2017 | 49 | 0.060 |
Why?
| | GPI-Linked Proteins | 2 | 2017 | 81 | 0.060 |
Why?
| | Epigenesis, Genetic | 2 | 2021 | 693 | 0.060 |
Why?
| | Cell Adhesion | 2 | 2018 | 451 | 0.060 |
Why?
| | Molecular Targeted Therapy | 2 | 2019 | 441 | 0.060 |
Why?
| | Mice, Nude | 2 | 2018 | 680 | 0.060 |
Why?
| | Neurons | 1 | 2015 | 1652 | 0.060 |
Why?
| | Pupa | 1 | 2025 | 14 | 0.060 |
Why?
| | Biopsy | 2 | 2020 | 1082 | 0.060 |
Why?
| | Isotonic Solutions | 2 | 2016 | 42 | 0.060 |
Why?
| | Swine | 2 | 2018 | 826 | 0.060 |
Why?
| | Mitochondrial Membrane Transport Proteins | 1 | 2025 | 46 | 0.060 |
Why?
| | Glucose Transport Proteins, Facilitative | 1 | 2025 | 16 | 0.050 |
Why?
| | Isocitrate Dehydrogenase | 1 | 2025 | 72 | 0.050 |
Why?
| | Carbohydrate Metabolism | 1 | 2025 | 59 | 0.050 |
Why?
| | Mitochondrial Dynamics | 1 | 2025 | 40 | 0.050 |
Why?
| | Exosomes | 1 | 2026 | 104 | 0.050 |
Why?
| | Plateletpheresis | 1 | 2024 | 28 | 0.050 |
Why?
| | Deferoxamine | 1 | 2024 | 27 | 0.050 |
Why?
| | Cell Survival | 2 | 2019 | 1104 | 0.050 |
Why?
| | Antimalarials | 1 | 2024 | 35 | 0.050 |
Why?
| | Lipid Peroxidation | 1 | 2025 | 168 | 0.050 |
Why?
| | RNA Interference | 2 | 2017 | 475 | 0.050 |
Why?
| | Alanine | 1 | 2025 | 169 | 0.050 |
Why?
| | Indoleacetic Acids | 1 | 2024 | 10 | 0.050 |
Why?
| | Cell Division | 1 | 2026 | 757 | 0.050 |
Why?
| | Pyruvates | 1 | 2023 | 23 | 0.050 |
Why?
| | Cell Lineage | 1 | 2026 | 378 | 0.050 |
Why?
| | Lipopolysaccharides | 2 | 2018 | 858 | 0.050 |
Why?
| | Pneumococcal Infections | 1 | 2025 | 104 | 0.050 |
Why?
| | Organophosphates | 1 | 2025 | 179 | 0.050 |
Why?
| | Blood Glucose | 3 | 2020 | 2344 | 0.050 |
Why?
| | Respiratory Therapy | 1 | 2023 | 25 | 0.050 |
Why?
| | Systemic Inflammatory Response Syndrome | 1 | 2024 | 95 | 0.050 |
Why?
| | RNA, Small Interfering | 2 | 2016 | 638 | 0.050 |
Why?
| | Doxorubicin | 1 | 2026 | 403 | 0.050 |
Why?
| | Puberty | 1 | 2024 | 137 | 0.050 |
Why?
| | Africa South of the Sahara | 1 | 2023 | 54 | 0.050 |
Why?
| | CRISPR-Cas Systems | 1 | 2025 | 166 | 0.050 |
Why?
| | Endothelial Cells | 2 | 2020 | 878 | 0.050 |
Why?
| | Pantothenic Acid | 1 | 2023 | 5 | 0.050 |
Why?
| | Myeloid Cells | 1 | 2024 | 147 | 0.050 |
Why?
| | Acyl Coenzyme A | 1 | 2023 | 32 | 0.050 |
Why?
| | Dasatinib | 1 | 2023 | 58 | 0.050 |
Why?
| | Prospective Studies | 3 | 2021 | 8078 | 0.050 |
Why?
| | Iodine Radioisotopes | 1 | 2023 | 138 | 0.050 |
Why?
| | Cell Cycle | 1 | 2026 | 598 | 0.050 |
Why?
| | RNA Splicing Factors | 1 | 2023 | 66 | 0.050 |
Why?
| | Hand Strength | 1 | 2023 | 144 | 0.050 |
Why?
| | Heme | 1 | 2023 | 90 | 0.050 |
Why?
| | Pyrimidinones | 1 | 2023 | 125 | 0.050 |
Why?
| | Leukocytes, Mononuclear | 1 | 2025 | 574 | 0.050 |
Why?
| | Cellular Senescence | 1 | 2024 | 226 | 0.040 |
Why?
| | Gram-Negative Bacteria | 1 | 2022 | 80 | 0.040 |
Why?
| | Adipocytes | 1 | 2023 | 223 | 0.040 |
Why?
| | Thrombin | 1 | 2022 | 172 | 0.040 |
Why?
| | Cell Movement | 2 | 2017 | 963 | 0.040 |
Why?
| | Pyridones | 1 | 2023 | 209 | 0.040 |
Why?
| | Horses | 1 | 2022 | 226 | 0.040 |
Why?
| | RNA, Messenger | 2 | 2022 | 2805 | 0.040 |
Why?
| | Subcellular Fractions | 1 | 2021 | 73 | 0.040 |
Why?
| | Pyruvic Acid | 1 | 2021 | 51 | 0.040 |
Why?
| | Oncogenes | 1 | 2021 | 118 | 0.040 |
Why?
| | Culture Media, Conditioned | 1 | 2021 | 112 | 0.040 |
Why?
| | Protein-Lysine 6-Oxidase | 1 | 2020 | 14 | 0.040 |
Why?
| | Candidiasis | 1 | 2021 | 64 | 0.040 |
Why?
| | Dogs | 1 | 2022 | 478 | 0.040 |
Why?
| | Immunity | 1 | 2021 | 140 | 0.040 |
Why?
| | Blood Coagulation | 1 | 2022 | 274 | 0.040 |
Why?
| | Fatty Acids, Unsaturated | 1 | 2021 | 96 | 0.040 |
Why?
| | Phosphoproteins | 1 | 2023 | 337 | 0.040 |
Why?
| | Cochlea | 1 | 2021 | 73 | 0.040 |
Why?
| | Point Mutation | 1 | 2021 | 241 | 0.040 |
Why?
| | Cystine | 1 | 2020 | 17 | 0.040 |
Why?
| | Muscle Strength | 1 | 2023 | 332 | 0.040 |
Why?
| | Cohort Studies | 2 | 2021 | 6033 | 0.040 |
Why?
| | Coculture Techniques | 1 | 2021 | 247 | 0.040 |
Why?
| | Genome | 1 | 2022 | 305 | 0.040 |
Why?
| | Fat Body | 1 | 2020 | 9 | 0.040 |
Why?
| | Creatine | 1 | 2020 | 63 | 0.040 |
Why?
| | Longevity | 1 | 2021 | 178 | 0.040 |
Why?
| | Poly-ADP-Ribose Binding Proteins | 1 | 2019 | 33 | 0.040 |
Why?
| | Nuclear Receptor Subfamily 1, Group F, Member 1 | 1 | 2019 | 3 | 0.040 |
Why?
| | Phylogeny | 1 | 2023 | 917 | 0.040 |
Why?
| | DNA Topoisomerases, Type II | 1 | 2019 | 42 | 0.040 |
Why?
| | Electron Transport Chain Complex Proteins | 1 | 2019 | 20 | 0.040 |
Why?
| | Gene Deletion | 1 | 2021 | 392 | 0.040 |
Why?
| | Quality of Life | 2 | 2023 | 3211 | 0.040 |
Why?
| | Binding, Competitive | 1 | 2019 | 185 | 0.040 |
Why?
| | Megakaryocytes | 1 | 2019 | 34 | 0.040 |
Why?
| | Drug Screening Assays, Antitumor | 1 | 2019 | 194 | 0.040 |
Why?
| | Dietary Carbohydrates | 1 | 2020 | 147 | 0.040 |
Why?
| | Cryoprotective Agents | 1 | 2018 | 11 | 0.040 |
Why?
| | Osmotic Fragility | 1 | 2018 | 12 | 0.040 |
Why?
| | Macaca mulatta | 1 | 2019 | 186 | 0.040 |
Why?
| | Erythrocyte Indices | 1 | 2018 | 33 | 0.040 |
Why?
| | Transplantation, Autologous | 1 | 2020 | 301 | 0.040 |
Why?
| | Platelet Activation | 1 | 2019 | 99 | 0.040 |
Why?
| | Sex Factors | 1 | 2025 | 2110 | 0.040 |
Why?
| | Interleukin-3 Receptor alpha Subunit | 1 | 2018 | 17 | 0.040 |
Why?
| | Succinic Acid | 1 | 2018 | 46 | 0.040 |
Why?
| | Drug Design | 1 | 2019 | 175 | 0.040 |
Why?
| | Microglia | 1 | 2021 | 273 | 0.040 |
Why?
| | Glycerol | 1 | 2018 | 90 | 0.030 |
Why?
| | Double-Blind Method | 1 | 2023 | 2064 | 0.030 |
Why?
| | Transplantation, Heterologous | 1 | 2018 | 170 | 0.030 |
Why?
| | Structure-Activity Relationship | 1 | 2019 | 563 | 0.030 |
Why?
| | Acute Disease | 1 | 2021 | 1036 | 0.030 |
Why?
| | Creatinine | 1 | 2020 | 515 | 0.030 |
Why?
| | Inflammation Mediators | 1 | 2021 | 507 | 0.030 |
Why?
| | Purine Nucleotides | 1 | 2018 | 12 | 0.030 |
Why?
| | Gluconeogenesis | 1 | 2018 | 81 | 0.030 |
Why?
| | Sarcolemma | 1 | 2018 | 35 | 0.030 |
Why?
| | Methylation | 1 | 2018 | 242 | 0.030 |
Why?
| | Host-Pathogen Interactions | 1 | 2021 | 361 | 0.030 |
Why?
| | Diet, Western | 1 | 2018 | 88 | 0.030 |
Why?
| | Gene Expression Regulation | 2 | 2017 | 2601 | 0.030 |
Why?
| | Liquid-Liquid Extraction | 1 | 2017 | 13 | 0.030 |
Why?
| | Formic Acid Esters | 1 | 2017 | 3 | 0.030 |
Why?
| | Feeding Behavior | 1 | 2024 | 692 | 0.030 |
Why?
| | Crush Injuries | 1 | 2017 | 14 | 0.030 |
Why?
| | Metabolism | 1 | 2017 | 44 | 0.030 |
Why?
| | Swine, Miniature | 1 | 2017 | 89 | 0.030 |
Why?
| | Azacitidine | 1 | 2018 | 157 | 0.030 |
Why?
| | Biological Transport | 1 | 2018 | 424 | 0.030 |
Why?
| | DNA-Binding Proteins | 1 | 2025 | 1482 | 0.030 |
Why?
| | Caspase 1 | 1 | 2018 | 145 | 0.030 |
Why?
| | Precursor Cells, B-Lymphoid | 1 | 2017 | 41 | 0.030 |
Why?
| | Blood Proteins | 1 | 2019 | 239 | 0.030 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2018 | 241 | 0.030 |
Why?
| | Pyrroles | 1 | 2018 | 220 | 0.030 |
Why?
| | Rotarod Performance Test | 1 | 2017 | 15 | 0.030 |
Why?
| | Cytosol | 1 | 2018 | 213 | 0.030 |
Why?
| | Fluorenes | 1 | 2017 | 45 | 0.030 |
Why?
| | Sulfones | 1 | 2018 | 127 | 0.030 |
Why?
| | Monocarboxylic Acid Transporters | 1 | 2017 | 21 | 0.030 |
Why?
| | Plasma Membrane Calcium-Transporting ATPases | 1 | 2017 | 10 | 0.030 |
Why?
| | Random Allocation | 1 | 2018 | 365 | 0.030 |
Why?
| | Cross-Sectional Studies | 2 | 2020 | 5925 | 0.030 |
Why?
| | Gene Expression | 1 | 2022 | 1478 | 0.030 |
Why?
| | Cystathionine | 1 | 2016 | 22 | 0.030 |
Why?
| | Prevalence | 1 | 2024 | 2875 | 0.030 |
Why?
| | Anaerobiosis | 1 | 2017 | 65 | 0.030 |
Why?
| | Periodicity | 1 | 2016 | 58 | 0.030 |
Why?
| | Cell Respiration | 1 | 2017 | 105 | 0.030 |
Why?
| | Longitudinal Studies | 1 | 2024 | 2968 | 0.030 |
Why?
| | Nucleotides | 1 | 2017 | 129 | 0.030 |
Why?
| | Weaning | 1 | 2016 | 51 | 0.030 |
Why?
| | Femoral Fractures | 1 | 2017 | 84 | 0.030 |
Why?
| | Quality Control | 1 | 2017 | 161 | 0.030 |
Why?
| | Proteins | 1 | 2022 | 1023 | 0.030 |
Why?
| | NADP | 1 | 2016 | 52 | 0.030 |
Why?
| | Protein Folding | 1 | 2018 | 277 | 0.030 |
Why?
| | Interleukin-18 | 1 | 2018 | 234 | 0.030 |
Why?
| | Hydrazines | 1 | 2016 | 37 | 0.030 |
Why?
| | Ubiquitination | 1 | 2017 | 119 | 0.030 |
Why?
| | Bronchioles | 1 | 2016 | 29 | 0.030 |
Why?
| | Kidney | 1 | 2024 | 1497 | 0.030 |
Why?
| | Hydrogen Sulfide | 1 | 2016 | 47 | 0.030 |
Why?
| | Myoblasts | 1 | 2017 | 83 | 0.030 |
Why?
| | Discriminant Analysis | 1 | 2016 | 35 | 0.030 |
Why?
| | Sesquiterpenes | 1 | 2016 | 52 | 0.030 |
Why?
| | Deoxyglucose | 1 | 2016 | 51 | 0.030 |
Why?
| | Least-Squares Analysis | 1 | 2016 | 73 | 0.030 |
Why?
| | Cyclic AMP-Dependent Protein Kinases | 1 | 2017 | 125 | 0.030 |
Why?
| | Muscle Proteins | 1 | 2018 | 243 | 0.030 |
Why?
| | Triglycerides | 1 | 2018 | 520 | 0.030 |
Why?
| | Neoplastic Cells, Circulating | 1 | 2016 | 81 | 0.030 |
Why?
| | Receptors, Interleukin-1 | 1 | 2017 | 211 | 0.030 |
Why?
| | Cell Cycle Checkpoints | 1 | 2016 | 97 | 0.030 |
Why?
| | Mice, Mutant Strains | 1 | 2016 | 302 | 0.030 |
Why?
| | Neurodegenerative Diseases | 1 | 2018 | 143 | 0.030 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2017 | 155 | 0.030 |
Why?
| | Stem Cells | 1 | 2020 | 630 | 0.030 |
Why?
| | Analysis of Variance | 1 | 2018 | 1300 | 0.030 |
Why?
| | Hemodynamics | 1 | 2021 | 1118 | 0.030 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2017 | 267 | 0.030 |
Why?
| | Interleukin-1beta | 1 | 2018 | 390 | 0.030 |
Why?
| | Body Temperature | 1 | 2016 | 227 | 0.030 |
Why?
| | Endoplasmic Reticulum | 1 | 2018 | 264 | 0.030 |
Why?
| | Recovery of Function | 1 | 2020 | 716 | 0.030 |
Why?
| | Tumor Burden | 1 | 2017 | 325 | 0.030 |
Why?
| | Bison | 1 | 2015 | 4 | 0.030 |
Why?
| | Glutamic Acid | 1 | 2017 | 255 | 0.030 |
Why?
| | Models, Molecular | 1 | 2020 | 1599 | 0.030 |
Why?
| | Fibroblasts | 1 | 2021 | 1028 | 0.030 |
Why?
| | Crosses, Genetic | 1 | 2015 | 123 | 0.030 |
Why?
| | Gas Chromatography-Mass Spectrometry | 1 | 2015 | 125 | 0.030 |
Why?
| | Muscle Fibers, Skeletal | 1 | 2016 | 212 | 0.030 |
Why?
| | Body Size | 1 | 2015 | 88 | 0.030 |
Why?
| | Multivariate Analysis | 1 | 2018 | 1547 | 0.030 |
Why?
| | Calcium Signaling | 1 | 2017 | 245 | 0.030 |
Why?
| | Sirolimus | 1 | 2016 | 282 | 0.030 |
Why?
| | Glycosylation | 1 | 2015 | 173 | 0.030 |
Why?
| | Europe | 1 | 2015 | 421 | 0.030 |
Why?
| | Mice, SCID | 1 | 2015 | 369 | 0.030 |
Why?
| | Cluster Analysis | 1 | 2016 | 501 | 0.030 |
Why?
| | Transfection | 1 | 2017 | 927 | 0.030 |
Why?
| | Flow Cytometry | 1 | 2018 | 1165 | 0.030 |
Why?
| | Indoles | 1 | 2018 | 507 | 0.030 |
Why?
| | Pregnancy | 2 | 2018 | 7216 | 0.030 |
Why?
| | Intestines | 1 | 2017 | 354 | 0.030 |
Why?
| | Lysine | 1 | 2016 | 305 | 0.030 |
Why?
| | Running | 1 | 2017 | 233 | 0.030 |
Why?
| | Hyperglycemia | 1 | 2018 | 380 | 0.030 |
Why?
| | Seasons | 1 | 2016 | 538 | 0.030 |
Why?
| | Membrane Proteins | 1 | 2020 | 1166 | 0.030 |
Why?
| | Biomedical Research | 1 | 2020 | 719 | 0.030 |
Why?
| | Regression Analysis | 1 | 2016 | 1001 | 0.030 |
Why?
| | Skull | 1 | 2015 | 163 | 0.030 |
Why?
| | Exercise Test | 1 | 2017 | 630 | 0.030 |
Why?
| | Neoplasm Invasiveness | 1 | 2015 | 508 | 0.030 |
Why?
| | Postpartum Period | 1 | 2016 | 373 | 0.020 |
Why?
| | Drug Therapy, Combination | 1 | 2016 | 1043 | 0.020 |
Why?
| | Recombinant Proteins | 1 | 2017 | 1368 | 0.020 |
Why?
| | Up-Regulation | 1 | 2016 | 848 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2021 | 2933 | 0.020 |
Why?
| | Survival Analysis | 1 | 2016 | 1378 | 0.020 |
Why?
| | Transcription, Genetic | 1 | 2019 | 1454 | 0.020 |
Why?
| | Acute Lung Injury | 1 | 2016 | 307 | 0.020 |
Why?
| | Sequence Analysis, RNA | 1 | 2015 | 442 | 0.020 |
Why?
| | Neoplasm Metastasis | 1 | 2015 | 688 | 0.020 |
Why?
| | Body Mass Index | 1 | 2021 | 2447 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2020 | 3634 | 0.020 |
Why?
| | Athletes | 1 | 2016 | 425 | 0.020 |
Why?
| | Fetus | 1 | 2016 | 804 | 0.020 |
Why?
| | NF-kappa B | 1 | 2015 | 667 | 0.020 |
Why?
| | Gastrointestinal Microbiome | 1 | 2019 | 768 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 2015 | 2131 | 0.020 |
Why?
| | Molecular Sequence Data | 1 | 2015 | 2883 | 0.020 |
Why?
| | Protein Binding | 1 | 2017 | 2240 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2024 | 11794 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2019 | 8347 | 0.020 |
Why?
| | United States | 1 | 2015 | 16126 | 0.010 |
Why?
|
|
Nemkov's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|